The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self-administered ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
The U.S. Food and Drug Administration approved the first flu vaccine on Friday, which does not have to be administered by a health care provider, but it won’t be available in time for this respiratory ...
AstraZeneca’s Supplemental Biologics License Application for the approval of a self- or caregiver-administered option for Flumist Quadrivalent (Influenza Vaccine Live, Intranasal), a needle-free nasal ...
Please provide your email address to receive an email when new articles are posted on . The FDA will review what could be the first self-administered influenza vaccine. The vaccine, FluMist, is ...
Please provide your email address to receive an email when new articles are posted on . FluMist is now approved for self- or caregiver-administration for people aged 2 to 49 years. The nasal spray is ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003 FluMist is a nasal spray manufactured by AstraZeneca that has been ...